4//SEC Filing
BIOGEN IDEC INC. 4
Accession 0001127602-15-006518
$BIIBCIK 0000875045operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:54 PM ET
Size
16.5 KB
Accession
0001127602-15-006518
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Holtzman Steven H
EVP Corp Devel and Strategy
Transactions
- Exercise/Conversion
Restricted Stock Unit
2015-02-12−2,142→ 4,289 totalExercise: $0.00Exp: 2017-02-12→ Common Stock (2,142 underlying) - Exercise/Conversion
Common Stock
2015-02-12+2,142→ 6,669 total - Tax Payment
Common Stock
2015-02-12$392.11/sh−1,009$395,639→ 5,660 total - Exercise/Conversion
Restricted Stock Unit
2015-02-12−1,492→ 5,848 totalExercise: $0.00Exp: 2017-02-12→ Common Stock (1,492 underlying) - Other
Restricted Stock Unit
2015-02-12−954→ 4,894 totalExercise: $0.00Exp: 2017-02-12→ Common Stock (954 underlying) - Exercise/Conversion
Common Stock
2015-02-12+1,492→ 7,152 total - Tax Payment
Common Stock
2015-02-12$392.11/sh−703$275,653→ 6,449 total
Footnotes (3)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- [F2]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
- [F3]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 8:54 PM ET
- Size
- 16.5 KB